Participants (Total) | 13,568 | |||
---|---|---|---|---|
Average Age (years) | 38.69 | |||
Average Time Gap between Diagnosis and Approval (months) | 4.61 | |||
Age Group | No. of patients | No. of observations | ||
0-20 | 1,332 | 9.82% | 6474 | 9.71% |
21-30 | 2,786 | 20.53% | 13,970 | 20.95% |
31-40 | 3,646 | 26.87% | 18,273 | 27.40% |
41-50 | 2,914 | 21.48% | 14,191 | 21.28% |
51-60 | 1,895 | 13.97% | 9,185 | 13.77% |
61-70 | 758 | 5.59% | 3594 | 5.39% |
71+ | 237 | 1.75% | 994 | 1.49% |
Total | 13,568 | 100.00% | 66,681 | 100.00% |
Gender | ||||
No. of patients | No. of observations | |||
Male | 8,453 | 62.30% | 41,873 | 62.80% |
Female | 5,115 | 37.70% | 24,808 | 37.20% |
Total | 13,568 | 100.00% | 66,681 | 100.00% |
Original Phase | ||||
No. of patients | No. of observations | |||
Chronic | 11,414 | 84.14% | 57,728 | 86.57% |
Accelerated | 1,228 | 9.05% | 5,958 | 8.94% |
Blast Crisis | 923 | 6.80% | 2,995 | 4.49% |
Total | 13565 | 100.00% | 66,681 | 100.00% |
Current Phase | ||||
No. of patients 1 | No. of observations | |||
Chronic | N/A | 54,192 | 81.27% | |
Accelerated | 4,587 | 6.88% | ||
Blast Crisis | 2,794 | 4.19% | ||
Remission | 5,108 | 7.66% | ||
Total | 66,681 | 100.00% | ||
Status | ||||
No. of patients 1 | No. of observations | |||
Closed | N/A | 3,734 | 5.60% | |
Active | 62,947 | 94.40% | ||
Total | 66,681 | 100.00% |